Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher Kjaer

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
European Journal of Pharmacology|November 17, 2019
Implementing collaborative, active learning using peer instructions in pharmacology teaching increases students' learning and thereby exam performanceStine Sonne Carstensen, Christopher Kjaer, Sören Möller, et al.
Frontiers in Neurology|August 28, 2023
Real-world efficacy and tolerability of fremanezumab in adults with chronic migraine: a 3-month, single-center, prospective, observational studyChristopher Kjaer Cullum, Basit Ali Chaudhry, Thien Phu Do, et al.
Frontiers in Pain Research (Lausanne, Switzerland)|August 1, 2022
Use of Non-pharmacological Therapies in Individuals With Migraine Eligible for Treatment With Monoclonal Antibodies Targeting Calcitonin Gene-Related Peptide (CGRP)-Signaling: A Single-Center Cross-Sectional Observational StudyLucas Rundblad, Christopher Kjaer Cullum, Simona Sacco, et al.
Cephalalgia : an International Journal of Headache|January 12, 2024
No wearing-off effect of erenumab or fremanezumab for chronic migraine prevention: a single-center, real-world, observational studyAnna Maria Florescu, Lærke Vig Lannov, Samaira Younis, et al.
Scientific Reports|August 5, 2024
Average steps per day as marker of treatment response with anti-CGRP mAbs in adults with chronic migraine: a pilot studyFrederik Thal Jantzen, Basit Ali Chaudhry, Samaira Younis, et al.
Medicine and Science in Sports and Exercise|November 6, 2019
Neuromuscular Electrical Stimulation Preserves Leg Lean Mass in Geriatric PatientsAnders Karlsen, Christopher Kjaer Cullum, Kristoffer Larsen Norheim, et al.
The Journal of Headache and Pain|June 2, 2022
Real-world long-term efficacy and safety of erenumab in adults with chronic migraine: a 52-week, single-center, prospective, observational studyChristopher Kjaer Cullum, Thien Phu Do, Messoud Ashina, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
European Journal of Pharmacology|November 17, 2019
Implementing collaborative, active learning using peer instructions in pharmacology teaching increases students' learning and thereby exam performanceStine Sonne Carstensen, Christopher Kjaer, Sören Möller, et al.
Frontiers in Neurology|August 28, 2023
Real-world efficacy and tolerability of fremanezumab in adults with chronic migraine: a 3-month, single-center, prospective, observational studyChristopher Kjaer Cullum, Basit Ali Chaudhry, Thien Phu Do, et al.
Frontiers in Pain Research (Lausanne, Switzerland)|August 1, 2022
Use of Non-pharmacological Therapies in Individuals With Migraine Eligible for Treatment With Monoclonal Antibodies Targeting Calcitonin Gene-Related Peptide (CGRP)-Signaling: A Single-Center Cross-Sectional Observational StudyLucas Rundblad, Christopher Kjaer Cullum, Simona Sacco, et al.
Cephalalgia : an International Journal of Headache|January 12, 2024
No wearing-off effect of erenumab or fremanezumab for chronic migraine prevention: a single-center, real-world, observational studyAnna Maria Florescu, Lærke Vig Lannov, Samaira Younis, et al.
Scientific Reports|August 5, 2024
Average steps per day as marker of treatment response with anti-CGRP mAbs in adults with chronic migraine: a pilot studyFrederik Thal Jantzen, Basit Ali Chaudhry, Samaira Younis, et al.
Medicine and Science in Sports and Exercise|November 6, 2019
Neuromuscular Electrical Stimulation Preserves Leg Lean Mass in Geriatric PatientsAnders Karlsen, Christopher Kjaer Cullum, Kristoffer Larsen Norheim, et al.
The Journal of Headache and Pain|June 2, 2022
Real-world long-term efficacy and safety of erenumab in adults with chronic migraine: a 52-week, single-center, prospective, observational studyChristopher Kjaer Cullum, Thien Phu Do, Messoud Ashina, et al.
Pageof 1